Dasatinib Tablets IP

Key Benefits
- Used in the treatment of certain types of blood cancer
- Helps manage chronic myeloid leukaemia (CML)
- May be used for Philadelphia chromosome-positive acute lymphoblastic leukaemia (Ph+ ALL)
- Helps block abnormal cancer-causing protein signals
- Supports slowing the growth and multiplication of cancer cells
- Can be used when certain other leukemia treatments are not suitable or effective
How It Works
Dasatinib blocks the activity of abnormal tyrosine kinases, including BCR-ABL and other proteins involved in cancer-cell signaling. By interfering with these signals, it helps prevent cancer cells from multiplying and supports control of the disease.
How to Use
- Take Dasatinib exactly as prescribed by your doctor.
- It may be taken with or without food, preferably at the same time each day.
- Swallow the tablet whole with water; do not crush, chew, or break it unless specifically advised.
- Do not change the dose or stop treatment without medical advice.
- Regular blood tests and medical monitoring may be required during treatment.
- Inform your doctor if you develop persistent diarrhea, unusual bleeding, or other concerning symptoms.
Important Information
Dasatinib can cause side effects such as fatigue, headache, nausea, diarrhea, abdominal pain, rash, anemia, low platelet or white blood cell counts, and fluid retention. More serious complications may include bleeding, pleural effusion, pulmonary hypertension, heart problems, and severe infections. Inform your doctor about all medicines and medical conditions before starting treatment. Dasatinib may harm an unborn baby, so effective contraception is recommended during treatment and for the period advised by your doctor. Do not use it during pregnancy or breastfeeding unless specifically directed by a healthcare professional.